|
|||||
|
|
Maintained immunogenicity of chronic myeloid leukemia-derived dendritic cells in the presence of imatinib mesylate: implication for vaccination regimens. |
|
| Authors: | T M Westers J J W M Janssen I Houtenbos N C L Snoijs A A van de Loosdrecht G J Ossenkoppele |
| Abstract: | |
| Keywords: | |